• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情,现代大流行:从一线医护人员视角进行的系统综述

COVID-19, Modern Pandemic: A Systematic Review From Front-Line Health Care Providers' Perspective.

作者信息

Balla Mamtha, Merugu Ganesh Prasad, Patel Mitra, Koduri Narayana Murty, Gayam Vijay, Adapa Sreedhar, Naramala Srikanth, Konala Venu Madhav

机构信息

Department of Internal Medicine, University of Toledo and Promedica Toledo Hospital, Toledo, OH 43606, USA.

Division of Geriatric Medicine, Department of Family Medicine, University of Toledo, OH 43614, USA.

出版信息

J Clin Med Res. 2020 Apr;12(4):215-229. doi: 10.14740/jocmr4142. Epub 2020 Mar 30.

DOI:10.14740/jocmr4142
PMID:32362969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7188368/
Abstract

Coronavirus disease 2019 (COVID-19) caused infection in 168,000 cases worldwide in about 148 countries and killed more than 6,610 people around the world as of March 16, 2020, as per the World Health Organization (WHO). Compared to severe acute respiratory syndrome and Middle East respiratory syndrome, there is the rapid transmission, long incubation period, and disease containment is becoming extremely difficult. The main aim of this systematic review is to provide a comprehensive clinical summary of all the available data from high-quality research articles relevant to the epidemiology, demographics, trends in hospitalization and outcomes, clinical signs and symptoms, diagnostic methods and treatment methods of COVID-19, thus increasing awareness in health care providers. We also discussed various preventive measures to combat COVID-19 effectively. A systematic and protocol-driven approach is needed to contain this disease, which was declared as a global pandemic on March 11, 2020, by the WHO.

摘要

根据世界卫生组织(WHO)的数据,截至2020年3月16日,2019冠状病毒病(COVID-19)在全球约148个国家感染了16.8万例,导致全球6610多人死亡。与严重急性呼吸综合征和中东呼吸综合征相比,COVID-19具有传播迅速、潜伏期长的特点,疾病控制变得极为困难。本系统综述的主要目的是对高质量研究文章中所有与COVID-19的流行病学、人口统计学、住院趋势和结局、临床体征和症状、诊断方法及治疗方法相关的可用数据进行全面的临床总结,从而提高医疗服务提供者的认识。我们还讨论了有效抗击COVID-19的各种预防措施。需要采用系统且遵循方案的方法来控制这种于2020年3月11日被WHO宣布为全球大流行的疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb62/7188368/07e593814c33/jocmr-12-215-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb62/7188368/f1154b1acaff/jocmr-12-215-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb62/7188368/baa046121a5c/jocmr-12-215-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb62/7188368/5b148b013011/jocmr-12-215-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb62/7188368/f56769457038/jocmr-12-215-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb62/7188368/e32a8e9f2b0c/jocmr-12-215-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb62/7188368/07e593814c33/jocmr-12-215-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb62/7188368/f1154b1acaff/jocmr-12-215-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb62/7188368/baa046121a5c/jocmr-12-215-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb62/7188368/5b148b013011/jocmr-12-215-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb62/7188368/f56769457038/jocmr-12-215-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb62/7188368/e32a8e9f2b0c/jocmr-12-215-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb62/7188368/07e593814c33/jocmr-12-215-g006.jpg

相似文献

1
COVID-19, Modern Pandemic: A Systematic Review From Front-Line Health Care Providers' Perspective.新冠疫情,现代大流行:从一线医护人员视角进行的系统综述
J Clin Med Res. 2020 Apr;12(4):215-229. doi: 10.14740/jocmr4142. Epub 2020 Mar 30.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).严重急性呼吸综合征冠状病毒2(SARS-CoV-2;冠状病毒病-19)的流行病学、病毒学及临床特征
Clin Exp Pediatr. 2020 Apr;63(4):119-124. doi: 10.3345/cep.2020.00493. Epub 2020 Apr 2.
4
Travel-related control measures to contain the COVID-19 pandemic: a rapid review.旅行相关的控制措施以遏制 COVID-19 大流行:快速综述。
Cochrane Database Syst Rev. 2020 Oct 5;10:CD013717. doi: 10.1002/14651858.CD013717.
5
Coronavirus nCOVID-19: A pandemic disease and the Saudi precautions.冠状病毒nCOVID-19:一种大流行病及沙特的预防措施。
Saudi Pharm J. 2020 Jul;28(7):888-897. doi: 10.1016/j.jsps.2020.06.006. Epub 2020 Jun 18.
6
Tuberculosis结核病
7
Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.单独隔离或与其他公共卫生措施相结合以控制新冠病毒病:一项快速综述
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013574. doi: 10.1002/14651858.CD013574.pub2.
8
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.恢复期血浆或高免疫球蛋白用于 COVID-19 患者:一项实时系统评价。
Cochrane Database Syst Rev. 2021 May 20;5(5):CD013600. doi: 10.1002/14651858.CD013600.pub4.
9
International travel-related control measures to contain the COVID-19 pandemic: a rapid review.国际旅行相关防控措施以遏制 COVID-19 大流行:快速综述。
Cochrane Database Syst Rev. 2021 Mar 25;3(3):CD013717. doi: 10.1002/14651858.CD013717.pub2.
10
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病(COVID-19)疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.

引用本文的文献

1
SARS-CoV-2 infection and multi-organ system damage: A review.SARS-CoV-2 感染与多器官系统损伤:综述。
Biomol Biomed. 2023 Feb 1;23(1):37-52. doi: 10.17305/bjbms.2022.7762.
2
SARS-CoV-2 and influenza viruses: Strategies to cope with coinfection and bioinformatics perspective.SARS-CoV-2 和流感病毒:应对合并感染的策略和生物信息学视角。
Cell Biol Int. 2022 Jul;46(7):1009-1020. doi: 10.1002/cbin.11800. Epub 2022 Apr 2.
3
The Misattributed and Silent Causes of Poor COVID-19 Outcomes Among Pregnant Women.孕妇中 COVID-19 不良结局的误归因及隐匿原因

本文引用的文献

1
Novel coronavirus 2019-nCoV (COVID-19): early estimation of epidemiological parameters and epidemic size estimates.新型冠状病毒 2019-nCoV (COVID-19):流行病学参数和疫情规模的早期估计。
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200265. doi: 10.1098/rstb.2020.0265. Epub 2021 May 31.
2
Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?穿山甲是否是 2019 新型冠状病毒(SARS-CoV-2)的中间宿主?
PLoS Pathog. 2020 May 14;16(5):e1008421. doi: 10.1371/journal.ppat.1008421. eCollection 2020 May.
3
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.
Front Med (Lausanne). 2021 Oct 26;8:745797. doi: 10.3389/fmed.2021.745797. eCollection 2021.
4
An Examination of the Factors Affecting Community Pharmacists' Knowledge, Attitudes, and Impressions About the COVID-19 Pandemic.影响社区药剂师对新冠疫情的知识、态度和印象的因素考察
Turk J Pharm Sci. 2021 Oct 28;18(5):530-540. doi: 10.4274/tjps.galenos.2020.01212.
5
Early reports of epidemiological parameters of the COVID-19 pandemic.COVID-19 大流行的早期流行病学参数报告。
Western Pac Surveill Response J. 2021 May 11;12(2):65-81. doi: 10.5365/wpsar.2020.11.3.011. eCollection 2021 Apr-Jun.
6
Atypical bacterial co-infections among patients with COVID-19: A study from India.COVID-19 患者中的非典型细菌合并感染:来自印度的研究。
J Med Virol. 2022 Jan;94(1):303-309. doi: 10.1002/jmv.27324. Epub 2021 Sep 15.
7
Epidemiological and Clinical Characteristics of 217 COVID-19 Patients in Northwest Ohio, United States.美国俄亥俄州西北部217例新冠肺炎患者的流行病学和临床特征
Cureus. 2021 Apr 5;13(4):e14308. doi: 10.7759/cureus.14308.
8
Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leukocytes sequencing data set of patients with COVID-19.基于 COVID-19 患者血液白细胞测序数据集的 SARS-CoV-2 感染相关基因的全基因组筛选。
J Med Virol. 2021 Sep;93(9):5544-5554. doi: 10.1002/jmv.27093. Epub 2021 May 28.
9
Scoping review of COVID-19-related systematic reviews and meta-analyses: can we really have confidence in their results?新冠病毒相关系统评价和荟萃分析的范围综述:我们真的能对其结果有信心吗?
Postgrad Med J. 2022 May;98(1159):372-379. doi: 10.1136/postgradmedj-2020-139392. Epub 2021 Feb 26.
10
COVID-19 Dentistry-Related Aspects: A Literature Overview.COVID-19 牙科相关方面:文献综述。
Int Dent J. 2021 Feb;71(1):21-26. doi: 10.1111/idj.12601. Epub 2021 Jan 12.
合并症的患病率及其对 SARS-CoV-2 感染患者的影响:系统评价和荟萃分析。
Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12.
4
A case of coronavirus disease 2019 with twice negative nucleic acid testing within 8 days.1例新型冠状病毒肺炎患者8天内核酸检测两次呈阴性。
Chin Med J (Engl). 2020 Jun 20;133(12):1487-1488. doi: 10.1097/CM9.0000000000000788.
5
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.将临床批准的药物重新用于治疗 2019 年新型冠状病毒相关冠状病毒模型中的 2019 年冠状病毒病。
Chin Med J (Engl). 2020 May 5;133(9):1051-1056. doi: 10.1097/CM9.0000000000000797.
6
A confirmed asymptomatic carrier of 2019 novel coronavirus.一名确诊的2019新型冠状病毒无症状携带者。
Chin Med J (Engl). 2020 May 5;133(9):1123-1125. doi: 10.1097/CM9.0000000000000798.
7
Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea.韩国28例冠状病毒病的早期流行病学和临床特征
Osong Public Health Res Perspect. 2020 Feb;11(1):8-14. doi: 10.24171/j.phrp.2020.11.1.03.
8
Diagnosis and Management of First Case of COVID-19 in Canada: Lessons Applied From SARS-CoV-1.加拿大首例 COVID-19 病例的诊断与管理:从 SARS-CoV-1 中吸取的经验教训。
Clin Infect Dis. 2020 Nov 19;71(16):2207-2210. doi: 10.1093/cid/ciaa227.
9
Discovering drugs to treat coronavirus disease 2019 (COVID-19).发现治疗2019冠状病毒病(COVID-19)的药物。
Drug Discov Ther. 2020;14(1):58-60. doi: 10.5582/ddt.2020.01012.
10
Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report.COVID-19 中 SARS-CoV-2 RNA 复阳:一例报告。
Int J Infect Dis. 2020 Apr;93:297-299. doi: 10.1016/j.ijid.2020.03.003. Epub 2020 Mar 5.